chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tongue was numb for hour following vaccine and then resolved on its own. Significant pain at infection site lasting at least 48 hours -took Tylenol and ibuprofen. Significant nausea without vomiting starting approx. 12 hours after vaccination, took zofran to help, lasted up to 48 hours after receiving vaccine. Body aches started approximately 12 hours after vaccine and lasted 48 hours.
Had them at least twice a year or more since my 20's / Suspected vaccination failure; Had them at least twice a year or more since my 20's; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The age at vaccination was not reported. The patient had shingles twice a year or more. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required. This is 1 of 4 linked cases reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183413:Same reporter US-GLAXOSMITHKLINE-US2021AMR188669:Same reporter. US-GLAXOSMITHKLINE-US2021AMR188669:Same reporter US-GLAXOSMITHKLINE-US2021AMR183413:Same reporter. US-GLAXOSMITHKLINE-US2021AMR188646:Same reporter.
On 04/12/2002 developed raised, red quarter size area on right deltoid. On 04/13/2002 when seen in office had spread to 4.5 cm x 4cm raised, red, warm to touch area on right deltoid. Diagnosed with cellulitis; placed on Cefzil 250mg BID x 10 days.
pt recv OCT95 & 96 & the children devel a breakthrough case of chicken pos;No further details were provided;
sore arm; tiredness; Inadvertent administration of more than 2 doses; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm), FATIGUE (tiredness) and EXTRA DOSE ADMINISTERED (Inadvertent administration of more than 2 doses) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced MYALGIA (sore arm), FATIGUE (tiredness) and EXTRA DOSE ADMINISTERED (Inadvertent administration of more than 2 doses). On 13-Aug-2021, EXTRA DOSE ADMINISTERED (Inadvertent administration of more than 2 doses) had resolved. At the time of the report, MYALGIA (sore arm) and FATIGUE (tiredness) outcome was unknown.            No concomitant medication was provided. No treatment medication was given.    This case was linked to MOD-2021-291115 (Patient Link).
1 of 5 adults immunized from the same lot# who exp redness & swelling surrounding the immunization site;No further clinical details provided;
Patient experienced chest pain while exercising  18 days post vaccination. Patient prescribed Ibuprofen  800 mg TID x10 days and pending Cardiology  Specialist visit. Unknown outcome at this time.
Post vax, the pt had slight elevation of fever. He complained of pain in right arm. On 9/25/00, he developed redness and fever at site extending 4 cm. Taken to ER where warm compresses were applied and given Motrin.
CHILLS; FEVER; LEFT SIDE HEADACHE; LEFT SIDE OF FACE HURTING (FACE THROBBING); TEETH SORE AND CHEWING HURT; SORE IN THE ARM (SAME SIDE THAT WAS INJECTED); This spontaneous report received from a patient concerned a 40 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol use, non-smoker, and codeine allergy, and other pre-existing medical conditions included the patient was a healthy guy and does not see his doctor regularly. the patient never contracted covid.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1821286 expiry: 21-OCT-2021) dose was not reported, administered on 23-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-JUL-2021, the subject experienced sore in the arm (same side that was injected). On 27-JUL-2021, the subject experienced left side of face hurting (face throbbing). On 27-JUL-2021, the subject experienced teeth sore and chewing hurt. On 27-JUL-2021, the subject experienced left side headache. On 01-AUG-2021, the subject experienced chills. On 01-AUG-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103.5 F. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore in the arm (same side that was injected) on 26-JUL-2021, had not recovered from left side of face hurting (face throbbing), teeth sore and chewing hurt, and left side headache, and the outcome of fever and chills was not reported. This report was non-serious.
having arm pain; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number ZX27E, expiry date 16th September 2022) for prophylaxis.   In October 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient was vaccinated with 1st dose of Shingrix a month before that date of reporting. The patient still had arm pain at the time of reporting. No further details were reported. The reporter consent to follow up.
It was reported that an 11 year old female received a TD-Adult vaccination in her left arm on 3/29/00. Reportedly, sometime after the vaccination, the pt developed a 3" red area, raised and warm at the area of the injection. From correspondence received on 4/19/00, additional pt information was provided.
Contract pharmacist, administered dose of Moderna after the 6 hour punctured expiration time. This vial was left over from the previous day she administered doses and she used the same vial the next calendar day to do the first 8 doses for the day. Pt is being offered 2nd dose again, will schedule asap if pt agrees.
Home Covid-19 test kit positive on 05/22/2022. Test taken due to thick, copious sinus secretions, mild nausea, and irritated throat. Immediately began isolation at home. Notified people who had met in person the last 5 day. Precipitating event probably funeral attendance on 05/17/2022 without masking.  Video call with doctor's office at 3:30 p.m. on 05/23/2022. Decided eligible to Paxlovid treatment based on high blood pressure and 69 years of age. PA verified no health issues or medication contraindicated Paxlovid treatment. PA discussed treatment and possible side effects. Began Paxlovid treatment (2x daily) evening of 05/23/2022. Health good. Metallic taste in mouth due to Paxlovid.
Information has been received from a registered nurse referring to a 1 year old patient of unknown gender. On 24-FEB-2015 the patient was supposed to received first dose of M-M-R II and VARIVAX (Merck). On 24-FEB-2015, the patient was inadvertently administered VARIVAX (Merck) and PROQUAD (Merck) lot # K019101, expiration date unspecified, 0.5 ml, subcutaneous (Wrong vaccine administered). No adverse effects were reported. Additional information has been requested.
Sore arm that evening Fatigue and headache started approx 24 hours injection lasted for 2-3 days , headache intermittent w/ fatigue
16y with acute Chest pain, shortness of breath and palpitations with brief syncope while playing basketball. Troponin elevated to 731 and quickly began to downtrend. EKG and Echo wnl, no evidence of myopericarditis. Event began 6 days after dose 1. Required overnight hospitalization for evaluation. Troponins downtrending without intervention. Patient discharged home
Side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) had not resolved.            Concomitant medications was not provided.  Treatment medications was not provided.  Action taken with mRNA-1273 in response to events was not applicable.   Reporter did not allow further contact
Changes in menstrual cycle. Extreme and unbearable cramps and heavy bleeding. Hot flashes during period as well.
Mild allergic reaction-patient felt like throat was tightening /burning, seeing spots, dizziness
Her insomnia got worse after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Her insomnia got worse after 2nd dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ATORVASTATIN for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Her insomnia got worse after 2nd dose). The patient was treated with TRAZODONE ongoing since an unknown date for Chronic insomnia, at a dose of 50 mg. At the time of the report, INSOMNIA (Her insomnia got worse after 2nd dose) outcome was unknown.            This case was linked to MOD-2021-294902 (Patient Link).
pt states that the day of the vaccine her vaccinated arm became very painful and she eventually could not lift it.
Left upper arm swollen day after injection.  Developed red lines around arm on 1/7.  Swelling remains increased pain at site.  Went to ER for evaluation, was told had inflammation, given "shot" and oral antibiotics.
arm hurt; slight fever; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced fever and pain in arm. On an unknown date, the outcome of the fever and pain in arm were recovered/resolved.   It was unknown if the reporter considered the fever and pain in arm to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The patient experienced very slight fever for a day and patient's arm hurt for a couple of days.  The patient would saw what happened with the second dose. The follow-up would not possible as no contact details were available.
Weakness, Loss of limb on the area of vaccine given, stiffness, Unable to walk or sit up, Pain, Chest pain, Started the next  day in the morning around 500 AM.
RASH ON TORSO AND LEGS ROUGHLY 12 HOURS POST VACCINATION OF 1ST DOSE.
He tested positive for COVID-19 on 9/14/22. He had a sore throat, cough, slight fever, and really fatigued. Within a couple hours of testing positive, he started taking PAXLOVID and he will be taking it for five days. PAXLOVID worked great because he is feeling much better now. He did get a small rash and it is hard to tell if it was from the medication or COVID-19.
Tinnitus in both ears, intensity varies. Discontinued Atorvastatin and Ibuprofen, no change. Currently there does not seem to be any treatment for Tinnitus.
Covid-19 positive; Covid-19 positive; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from product quality group.  A female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 01May2021 (Lot number: EW0153) asdose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose product: COVID 19, dose brand: Pfizer BNT162B2, dose brand unknown: False, dose lot number: ER8736, dose lot unknown: False, dose administrator route: Intra muscular, dose administration date: 10Apr2021,dose number: 1, dose vaccine location: Left arm), administration date: 10Apr2021, for COVID-19 Immunization. The following information was reported: VACCINATION FAILURE, COVID-19 (medically significant) all with onset 27Dec2021, outcome "recovering". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (27Dec2021) positive, notes: Nasal swab. Therapeutic measures were taken as a result of vaccination failure, covid-19. It was reported that, the patient had not received other vaccine in four weeks. No Other medications in two weeks. It was reported that, the patient did not diagnosed with COVID-19 Prior to vaccination. It was reported that, the patient had been tested for COVID-19 Since the vaccination.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Based on the  information in the case report, a possible causal relationship between the events Vaccination failure, Covid-19  and suspect drug BNT162B2 cannot be excluded.
the patient was administered an improperly stored dose of VAQTA; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concomitant therapies, drug allergies and concurrent condition were not provided.  On 26-MAY-2020, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) (lot # S032055, expiration date 09-NOV-2020; dose detail, strength and route were not provided) for prophylaxis (product storage error). The temperature excursion included 12.1 Celsius degree for 16 hours and 11 minutes. There was no preciously temperature excursion. There was a data logger involved. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; manufactureraddress: ; manufacturercity:  ; manufacturerstate: ; manufacturercountry:  devicelotnumber: S032055; expirationdate: 09-NOV-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Dizziness that started within less than 60 seconds of getting the shot and turned into daily headaches for the next 5 weeks. Tendor right arm, where I got the shot. On April 8 my arm pain felt worse. I had chest tightness starting the 9th. by April 10th the whole right side of my body was week and sore/tender. Chest pain/ pressure/tightness  was coming in waves every 30 minutes to an hour, all day. Weakness on right side and chest pain got better by 4/13. 4/16 I noticed bruises on my right and left leg. I got more bruises and had leg spasms for the next two weeks. Headaches got worse 4/21. I was denied my second shot by 3 medical staff members at the Javits center; they recommended getting my second dose in a hospital setting after medical clearance. When I was able to see my GP for antibody test and advise she said to wait 6 months since I still had headaches and bruises.
She got her vaccine, the arm was a little sore.  Then about 30 minutes had sinus problems, but then for 2 days she had fever and chills.  Then the ringing in her ears started within a week after that.  She does have tinnitus but it intensified since the vaccine.  She had a teleconference call with her doctor who told her that it was not one of the symptoms of the vaccine and told her to have her hearing checked.
Symptoms started approx. 24 hours later. Reports ?severe rash? along throat and chest, and swelling in face along cheekbones and under they eyes. Rash started to dissipate on its own after 1-2 days. Swelling continued so he started Benedryl on his own. Swelling decreased but has not completely subsided. Went to his PCP, she provided an Rx (wasn?t sure what it was at this time). Patient states PCP reports not worried about him getting a second dose
Information has been received from a healthcare worker concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 07-MAY-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck), lot # L002419, expiration date 23-JUL-2016 (dose and route not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because the physician did not wish to be contacted.
Contacted management, Provider, filled out a form, notified patient and filled out this VAERS report
Localized hives at inj site following imms - resolved with BENADRYL 37.5 mg.
Violent vertigo attack; Felt like the world was going in one direction and she was going in anothe; legs felt very heavy; Eyes are burning; Head was heavy; Tired; Head felt like it was splitting; Aches and pains; A spontaneous report was sent by a consumer who is a female patient of unknown age that received Modern's COVID-19 vaccine (mRNA-1273) and experienced vertigo, legs felt heavy/restless legs, fatigue, head was heavy/ tension headache, head felt like it was splitting/headache, and aches and pains/myalgia.   The patient's medical history was unknown. Concomitant medication included Nexium.  On 08-FEB-2021, the patient received the first dose of mRNA-1273 for prophylaxis of COVID-19 infection.   She developed adverse events after this initial dose but these are part of a separate case.  On 08-MAR-2021, prior to the onset of the events, the patient received the second dose of mRNA-1273 for prophylaxis of COVID-19 infection.  Around 14-MAR-20221, she experienced violent vertigo attack where the world is going in one direction and she was going in another. Her head felt like it was spitting at this time. The patient was admitted to the hospital on 14-MAR-2021 around 12 AM and discharged by 6 AM on the same day and prescribed with Meclizine. The provided treatment made her head heavy and it made her felt tired. Her legs feel very heavy and she has aches and pains. She also described her eyes are burning.  The seriousness criteria for the event vertigo were reported as hospitalization and medically significant.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable..   The outcome of the events, vertigo, legs felt heavy/restless legs, fatigue, head was heavy/ tension headache, head felt like it was splitting/headache, and aches and pains/myalgia was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the vertigo and headache, a causal relationship cannot be excluded. Based on reporter's causality, the head felt heavy, tiredness, and eyes burning is assessed as unlikely related to mRNA-1273 and related to meclizine.
COUGH; FEVER; MUSCLE ACHES; CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; INCREASED DREAMS; This spontaneous report received from a physician concerned a 34 year old of unknown ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number and expiry: Unknown) 1 total, administered on 18-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On JUN-2021 (This started a day or two after receipt of the vaccine), the patient experienced increased dreams and and physician was wondering if this was related to lack of antibodies. On 22-NOV-2021, the patient underwent though antibodies test with a  made home-antibody test (confirmed immunological vaccine failure). exact type of antibody test not reported. It was also reported that physician does not know if the made test was reliable and the antibody test results were found to be negative for IgG and IgM. the patient received vaccine at a trailer (that moves all over) along with this patient had increased dreams (non-specific) after receiving the Janssen Covid-19 vaccine. On an unspecified date, the patient experienced cough, fever, and muscle aches and it's unclear if he had Covid-19. It was also stated that it could be something else (like a cold or Flu), as the patient has not received a flu-shot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from increased dreams on 01-NOV-2021, and the outcome of confirmed immunological vaccine failure, fever, cough and muscle aches was not reported. This report was serious (Other Medically Important Condition). This report was associated with regulatory authority:90000203429.; Sender's Comments: V0; 20211149757-COVID-19 VACCINE AD26.COV2.S-Confirmed immunological vaccine failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Dry cough. " A little chest tightness." states physician.  Friend told him he had Oculo-Respiratory Syndrome-an adverse event found after Canadian flu vaccine.
C/O sitting in class writing when arm became weak. No other SX (equal grasp bilat; 1-2 sec cap refill bilat). Monitored for approx. 1 hr. SX continued with change. Telephone call to mom informed of SX. Mom started to send back to class, she would watch and contact PCP if sx persist.